MedTrace Logo

A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC

NCT06360952 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-05-21

No results posted yet for this study

Summary

This study will evaluate the feasibility of using capillary blood samples collected with the Tasso device for analysis of CBC in diseased patients with leukemia, lymphoma, and/or other blood cell disorders.

This investigation will include a minimum of 40 sample sets from unique patients.

Conditions

Interventions

DEVICE

Tasso+ CBC

Novel blood collection device

Sponsors & Collaborators

  • The Leukemia and Lymphoma Society

    collaborator OTHER

  • Tasso Inc.

    lead INDUSTRY

Principal Investigators

  • Erwin Berthier, Phd · Tasso Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-31
Primary Completion
2024-08-31
Completion
2024-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06360952 on ClinicalTrials.gov